60 Degrees Pharmaceuticals Inc. (SXTP)
SXTP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9000
-1.70% on the day
Market cap
$3.2M
Nano cap
Revenue · 2025
$1.0M
+65.5% on 2024
Net income · 2025
-$7.4M
-732.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SXTP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001946563 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.0M |
| Net income | -$7.4M |
| Operating income | -$7.8M |
| Net margin | -732.5% |
| Operating margin | -771.6% |
| Revenue growth | +65.5% |
| Cash | $1.5M |
| Total assets | $5.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-3 | 2026-08-14 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-06 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-07-02 |
Source: SEC EDGAR submissions feed, 220 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| SXTPW | 60 Degrees Pharmaceuticals Inc. Warrant | $0.0246 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CMND | Clearmind Medicine Inc. Common Shares | $6.23 | -4.74% | $3.2M |
| RDHL | Redhill Biopharma Ltd. | $0.5150 | -3.45% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
| CAPS | Capstone Holding Corp. | $0.1242 | -6.83% | $3.3M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| EOCN | Eocene Ltd. | $3.17 | -1.71% | $3.3M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| GRI | GRI Bio Inc. | $1.55 | -1.27% | $3.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier